MedBiome participates in Bio Europe

Published on: 05 November, 2018

Dr. Alain Stintzi and Dr. Daniel Figeys were at Bio Europe in Copenhagen in November 2018. They presented the RapidAIM platform to rapidly study the effects of drugs and other compounds on individual human microbiome. They also presented their therapeutic development for pediatric IBD.

Innovations on human gut microbiome based drug discoveries

MedBiome focuses on the development of drugs that target the human microbiome. Our mission is to identify drugs that target the microbiome to improve human health.

MedBiome was launched in 2018 as the result of technologies developed at the University of Ottawa.

MedBiome is located in Ottawa, ON, Canada.

© 2019. MedBiome, Inc. All Rights Reserved.

Quick Links

Admin Access

  • Log In
MicroBiome Inc. LOGO